NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View

In the 2020 European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndromes (NSTE-ACS), the experts proposed to put an end to the equipoise of ticagrelor and prasugrel in addition to aspirin in patients with NSTE-ACS who proceed to percutaneous coronary intervention (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Angoulvant, Denis, Sabouret, Pierre, Savage, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435520/
https://www.ncbi.nlm.nih.gov/pubmed/33674980
http://dx.doi.org/10.1007/s40256-021-00471-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435520/
https://www.ncbi.nlm.nih.gov/pubmed/33674980
http://dx.doi.org/10.1007/s40256-021-00471-z

Ejemplares similares